ESAB Q4 sales fall 3% to $671 million while diluted EPS rises to $1.18; 2025 guidance issued
ESAB reported fourth quarter 2024 sales of $671 million, down 3% on a reported basis but flat on a core organic basis, and net income from continuing operations attributable to ESAB of $72 million, or $1.18 per diluted share. The company also issued full-year 2025 guidance, expecting core adjusted EBITDA of $515 million to $530 million and core adjusted EPS of $5.10 to $5.25, which shareholders can compare with 2024 core adjusted EPS of $5.06.
Key points
- Q4 2024 net sales $671 million, down 3% reported; core organic growth flat
- Q4 2024 diluted EPS $1.18 from continuing operations; core adjusted EPS $1.28 versus $1.13 a year earlier
- Core adjusted EBITDA $129 million, up 2%; margin 20.3%, up 90 basis points
- 2025 guidance: core sales growth (2.0)% to 0.0%; core adjusted EBITDA $515 million to $530 million
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.